News
-
-
COMMUNIQUÉ DE PRESSE
Aquis Stock Exchange: Application for Admission Announcement
Falconedge Plc applies for admission to the AQSE Growth Market, offering turnkey advisory solutions for asset and fund managers. Led by experienced executives, with focus on sustainable growth and embracing new technologies -
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
THX Pharma announces the launch of a capital increase with preferential subscription rights of nearly EUR 8 million
THX Pharma launches a €8 million capital increase to fund rare neurological drug development, with 75.5% commitments secured. Batten-1 and TX01 to lead clinical and commercial endeavors with strategic shift to international markets. Investment opportunities for various tax schemes -